CAR T-cell therapy effective for chronic lymphocytic leukemia – Healio
|
CAR T-cell therapy effective for chronic lymphocytic leukemia
Healio CD19-specific chimeric antigen receptor-modified T–cell therapy induced durable molecular remissions in patients with high-risk chronic lymphocytic leukemia who had previous treatment failure with ibrutinib, according to results from a phase 1/phase 2 … |
